MedTrace Logo

Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma

NCT01137565 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2014-03-04

No results posted yet for this study

Summary

The purpose of this study is to study the safety and tolerability in adolescent and adult subjects with intermittent or mild to moderate persistent asthma.

Conditions

Interventions

DRUG

AMG 853

Single dose administration of AMG 853 or placebo in tablet form to adolescent and adult subjects with asthma

DRUG

Placebo

Placebo to AMG 853

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-01-31
Completion
2011-01-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01137565 on ClinicalTrials.gov